You are here

  • Home
  • Archive
  • Volume 16, Issue 5
  • Oral rivaroxaban for acute DVT, or long term for VTE, is as effective as enoxaparin followed by a vitamin K antagonist for preventing recurrence, with no increase in bleeding complications

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Oral rivaroxaban for acute DVT, or long term for VTE, is as effective as enoxaparin followed by a vitamin K antagonist for preventing recurrence, with no increase in bleeding complications

https://doi.org/10.1136/ebm1301

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests DR has served on speakers bureau of Sanofi Aventis, has received research grant support from Sanofi Aventis and serves on an advisory board for Canyon Pharmaceuticals. JA has served as a consultant for Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo and Ortho McNeil.